Region Oerebro Laen

Research activity includes treatment strategies for advanced breast cancer in older patients, with attention to CDK 4/6 inhibitors, endocrine therapy, and extended adjuvant treatment in high-risk luminal breast cancer. The portfolio also reflects interest in treatment optimisation for vulnerable and frail patients.

• Advanced breast cancer in older patients
• CDK 4/6 inhibitor treatment
• Endocrine therapy sequencing
• High-risk luminal breast cancer

The focus spans both systemic treatment selection and long-term hormonal management in breast oncology.